Moderna and Merck report mRNA cancer vaccine cut deaths and recurrence by 42%

·1 views

Moderna and Merck have released top-line results from a trial of their mRNA cancer vaccine. The companies say the vaccine reduced deaths and cancer recurrence by 42%. The announcement follows earlier reports that the trial had succeeded. The release provides the first detailed figures on the vaccine's effect in the study. Further details from the full trial data have not yet been made public.

Read the full story at Ars Technica

This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)

Researchers left 13 AI agents on a virtual island; they invented games and improved

MIT researchers placed 13 AI agents on a virtual island with no assigned tasks. Instead of sitting idle, the agents devised games for themselves. The agents also reportedly showed signs of mourning after a ring was lost. Over time, they became more effective at their intended jobs.

0 comments Read more at TechCrunch

TechnologyThe Verge ·

Etsy tightens rules on AI-generated listings to curb misleading content

Etsy is introducing stricter policies governing how artificial intelligence can be used in product listings on its marketplace. The company said many buyers cannot tell which items involve AI-generated content, and sellers have voiced concern about appearing alongside items that use AI misleadingly. Under the new rules, each listing must include at least one unedited photo of the actual item against a real background. All photos must also accurately represent what a buyer will receive, though non-primary images may be edited with software.

0 comments Read more at The Verge

TechnologyTechCrunch ·

Zuckerberg Reportedly Structured New Meta Stock Class to Ease Possible California Billionaire Tax

Meta has launched a new stock class that was partly designed to help CEO Mark Zuckerberg cover a proposed California billionaire tax if it becomes law. The measure has not yet been approved by voters or lawmakers. The arrangement appears intended to let Zuckerberg meet a potential tax bill without giving up his control over the company. The details are drawn from a report that describes the stock offering as having been engineered with that purpose in mind.

0 comments Read more at TechCrunch

TechnologyTechCrunch ·

Warhound raises $200M to engineer military dogs and equip them with Anduril gear

Warhound, a company founded by Ben Lamm and Palmer Luckey, has emerged from stealth mode. The firm aims to genetically engineer dogs for use by military and law enforcement agencies. It has reportedly secured $200 million in funding to pursue this work. The dogs are intended to be outfitted with equipment from Anduril, the defense technology company co-founded by Luckey. The announcement marks the company's first public disclosure of its mission.

0 comments Read more at TechCrunch